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A B S T R A C T
Hybrid drug delivery systems (DDS) have been prepared by grafting poly(NIPAM-co-MPS) chains
on multimodal porous silica nanoparticles having an inner mesoporous structure and an
outer thin layer of micropores. The hybrid thermoresponsive DDS were fully characterized
and loaded with a model drug. The in vitro drug release tests are carried out at below and
above the lower critical solution temperature (LCST) of the copolymer. The results have re-
vealed that due to the presence of small diameter (~1.3 nm) micropores at the periphery
of the particles, the collapsed globules of the thermoresponsive copolymer above its LCST
hinders the complete release of the drug which resulted in a reverse thermoresponsive drug
release profile by the hybrid DDS.
© 2017 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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1. Introduction
Mesoporous silica nanoparticles (MSNs) have emerged as one
of the most efficient drug delivery systems for the delivery of
various drug molecules [1–4]. Easy synthesis and surface modi-
fication methods, good stability and biocompatibility are the
characteristic properties that make MSNs versatile material
in drug delivery applications [5]. The transformation of bare
MSNs into controlled thermosensitive drug delivery systems
(DDS) is carried out by grafting of thermoresponsive poly-
mers such as poly(N-isopropylacrylamide) or its various
copolymers on the particle outer surface or/and on the inner
pore walls [6–8]. Poly(N-isopropylacrylamide) (PNIPAM) is a water
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soluble thermoresponsive polymer which shows a typical coil-
to-globule transition at its lower critical solution temperature
(LCST) which is around 32 °C [9,10]. The LCST of the polymer
can be tuned toward higher values by preparing various co-
polymers of PNIPAM [11]. Above LCST, the water soluble
extended chains of the polymer collapse to form compact in-
soluble globules. As the volume occupied by the polymer in
its hydrated coil form is much higher than the collapsed glob-
ules, this transition applies a pore opening–pore closing
mechanism to the MSNs [6–8].
If the transition of the thermoresponsive polymer occurs
inside the pores of the MSNs, at temperatures below the LCST
the hydrated extended chains of the polymer block the pores,
which prevent the release of the drug molecules loaded inside
the MSNs. Instead upon heating above the LCST, the polymer
chains collapse toward the pore walls which opens the pores
and completely releases the drug.Thus a normal drug release
profile of such thermosensitive DDS shows reduced or no
release of the drug at temperatures below the LCST of the
polymer and higher or complete release of the drug above
the LCST of the polymer. However, the pore size can also play
an important role in the pore opening/closing mechanism.
This role of microporosity in thermoresponsive DDS needs to
be investigated. Related to this in the present work we report
about the influence of pore size in designing thermoresponsive
DDS where the presence of micropores on the surface of MSNs
can result in a reverse thermoresponsive drug release profile.
This occurs due to the full or partial blockage of the micropores
by the collapsed globules of the thermoresponsive copoly-
mer.This work therefore points out an important consideration
about the proper choice of MSNs and diameter of the
pores present on them for their use for preparation of
thermoresponsive DDS.
2. Materials and methods
2.1. Materials
Porous silica particles (particle size 200 nm, pore size 4 nm),
N-isopropylacrylamide (NIPAM), azobisisobutyronitrile (AIBN),
3-(methacryloxypropyl) trimethoxysilane (MPS), ibuprofen (stan-
dard RS α-methyl-4-(isobutyl)phenylacetic acid, (±)-2-(4-
isobutylphenyl) propanoic acid) were purchased from Sigma-
Aldrich, Italy. All the solvents mentioned in the synthesis
procedure were of high purity and used as received. Ethanol
was kept on molecular sieves overnight before using for po-
lymerization reaction.
2.2. Instruments and methods
High resolution transmission electron microscopy (HRTEM)
images were obtained with a JEOL 2010 instrument (300 kV)
equipped with a LaB6 filament. For specimen preparation
powdery samples were supported onto holed carbon coated
copper grids by dry deposition.
Fourier transform infrared spectroscopy (FTIR) spectra were
collected with a Perkin Elmer FTIR Nexus instrument equipped
with an attenuated total reflectance (ATR) devise (Thermo
Nicolet Smart Endurance) and with a DTGS detector.The spectra
were collected in the spectral range of 4000–670 cm−1 and with
a resolution of 4 cm−1.
Gas-volumetric analysis, specific surface area (SSA), pore
volume and size were measured by N2 adsorption–desorption
isotherms at 77 K using an ASAP 2020 (Micromeritics) gas-
volumetric analyzer. SSA was calculated using the Brunauer–
Emmett–Teller (BET) method. Porosity distribution, allowing one
Fig. 1 – (A) Grafting of the copolymer on MSNs, (B) structure of the copolymer and (C) coil-to-globule transition of the grafted
copolymer on the surface of MSNs.
280 a s i an j o u rna l o f p h a rma c eu t i c a l s c i e n c e s 1 2 ( 2 0 1 7 ) 2 7 9 – 2 8 4
to estimate width and volume, was calculated with the non-
local density functional theory (NLDFT), employing the N2-
DTF model with slit pore geometry (regularization low). The
samples were kept in an oven at 50 °C for 4 h and then out-
gassed at RT overnight before analysis.
Size exclusion chromatography (SEC) was performed with
a Viscotek modular instrument equipped with a VE 1122
pump, a VE 7510 degasser, manual injection valve, VE 3580
refractive index detector, column oven and two PLgel
10 μm MIXED-B columns (Polymer Laboratories, UK). N,N-
Dimethylformamide (DMF) (1.0 ml/min) was used as eluent.
Due to the density of DMF, analyses were performed setting
the column oven at 70 °C.
Thermogravimetric analyses (TGA) were carried out on a
TA Q500 model fromTA Instruments by heating samples con-
tained in alumina pans at a rate of 10 °C/min from 25 to 800 °C
in air. A differential scanning calorimeter (DSC Q200, TA Inc.)
was used to collect DSC thermograms of the samples.Weighed
quantity of samples was placed in sealed aluminum pans and
DSC measurements were performed under nitrogen atmo-
sphere with heating rate of 10 °C/min.
UV–visible analyses were performed using a Lambda 15 UV–
Vis spectrophotometer (Perkin Elmer). For ibuprofen
quantification a calibration curve (ε = 185.1 M−1, R2 = 0.99) was
obtained by plotting absorbance vs. concentration of ibupro-
fen between 6.0 × 10−5 and 4.8 × 10−4 M.
2.3. Preparation of poly(NIPAM-co-MPS)-grafted MSNs
The copolymer-grafted mesoporous nanoparticles were ob-
tained by carrying out the synthesis of the copolymer in ethanol
in the presence of the particles. MSNs (280 mg) were dis-
persed in 10 ml of ethanol solution of NIPAM and AIBN by
sonication at room temperature.The NIPAM/MSNs weight ratio
was 1:4. After 30 min MPS was added into the suspension and
dispersed evenly by sonication for another 30 min. The dis-
persion was then injected in a three neck round bottom flask
equipped with condenser and kept under nitrogen atmo-
Fig. 2 – (A, B) TEM images of MSNs, (C) N2 adsorption desorption isotherms and (D) pore size distribution curve of the MSNs.
Table 1 – The synthesis conditions and properties of the copolymer.
Polymer NIPAM/MPS NIPAM/AIBN NIPAM/MSNs Mn (Da) Mw (Da) PDI LCST (°C)
Poly(NIPAM-co-MPS) 20:1 30:1 1:4 8,500 19,000 2.2 36
281a s i an j o u rna l o f p h a rma c eu t i c a l s c i e n c e s 1 2 ( 2 0 1 7 ) 2 7 9 – 2 8 4
sphere.The injected suspension was then heated at 70 °C under
nitrogen for 16 h. The white residue of polymer grafted-
particles obtained was transferred in a test tube and washed
two times with 5 ml of deionized water and once with 5 ml
of ethanol. Each time the liquid phase was separated by cen-
trifugation.The final product obtained was dried under vacuum
for several hours before characterization.
2.4. Drug loading and release tests
Ibuprofen was selected as model drug for loading and release
tests. MSNs were outgassed at RT overnight to remove ad-
sorbed water and then were dispersed under magnetic stirring
in a hexane solution of ibuprofen (0.16 M) at 40 °C for 48 h.Then
nanoparticles were separated by centrifugation, washed once
with hexane and dried at RT. Ibuprofen loading was deter-
mined by TGA. The loading was calculated from TGA by
subtracting from the total weight loss the contribution due to
the copolymer, adsorbed water and dehydroxylation.
In vitro drug release tests were carried out in physiological
saline solution (PSS). The release profiles in PSS were ob-
tained by monitoring the absorbance peak of ibuprofen at
272 nm at different time intervals and at well below the LCST
(4 °C) which is also the storage temperature of suspension of
drugs and above the LCST (40 °C) of the copolymer.
3. Results and discussion
3.1. Synthesis and characterization of poly(NIPAM-co-
MPS)-grafted MSNs
The scheme for the post-synthesis surface grafting of
thermoresponsive random copolymer poly(NIPAM-co-MPS) on
MSNs is shown in Fig. 1.The reactivity of surface silanol groups
present on MSNs is exploited for anchoring of the copolymer
[12–14].TheTEM images, N2 adsorption isotherms and pore size
distribution of the MSNs used in this work are shown in Fig. 2.
The average diameter of the particles is approximately 190–
200 nm. The ordered porous structure is clearly visible, while
the magnified TEM image of a single particle revealed that a
border of microporous channels of approximately 15–25 nm in
length is present at the periphery of the particles. This
multimodal porous structure was further confirmed by
porosimetry. Specific surface area of the particles calculated
by BET method was 901 m2/g. The pore diameter distribution
curve, calculated by NLDFT, clearly showed the presence of
micropores (1.3 nm in diameter) and mesopores (4 nm in di-
ameter) on the particles. During the copolymerization in the
presence of MSNs diffusion of NIPAM andMPSmonomers inside
the pores may be limited due to the very small diameter of
the porous channels at the periphery of the nanoparticles.This
resulted in grafting of the copolymermostly on the outer surface
of the particles.The reaction conditions for the polymer graft-
ing and properties of the copolymer are reported in Table 1.
The copolymer grafting on MSNs was confirmed by ATR-FTIR
spectroscopy. The results obtained are shown in Fig. 3 which
shows ATR-FTIR spectra of bare and polymer-grafted
nanoparticles. The characteristic peaks of the copolymer due
to C—H (bend.) at 1370, CH3 (bend.) at 1391 cm−1, C—N (stretch.)
at 1460, 1545 cm−1, amide C=O (stretch.) at 1640 cm−1 and
acryloxy C=O (stretch.) from MPS at 1707 cm−1 were ob-
served in the spectrum of poly(NIPAM-co-MPS)-grafted MSNs
[6,13]. While the spectra of ibuprofen-loaded hybrid MSNs
showed the presence of characteristic peaks of ibuprofen. Es-
pecially the peak at 1719 cm−1 due to C=O (stretch.) was clearly
evident. This confirmed the loading of ibuprofen inside
poly(NIPAM-co-MPS)-grafted MSNs.
3.2. Quantitative polymer grafting and drug loading
TGA curves of bare MSNs and poly(NIPAM-co-MPS)-grafted MSN
samples are shown in Fig. 4A. Bare MSNs showed good thermal
stability as upon programmed heating up to 800 °C only 0.25%
of weight loss was observed for the particles. The weight loss
for poly(NIPAM-co-MPS)-grated MSNs was 11.35% and for
ibuprofen-loaded hybrid nanoparticles it was 27.5%.These data
were used to calculate the amount of grafted copolymer and
the drug loading. The calculated percentage of grafted copo-
lymer was 11.1%, while the quantitative loading of ibuprofen
obtained was 16.15%. The ibuprofen loaded inside the hybrid
porous particles is in amorphous state as no signs of crystal-
lization of the ibuprofen incorporated in hybrid porous silica
were detected with DSC (Fig. 4B).
Fig. 3 – ATR-FTIR spectra of (A) bare, (B) poly(NIPAM-co-
MPS)-grafted MSNs, (C) ibuprofen loaded poly(NIPAM-co-
MPS)-grafted MSNs and (D) ibuprofen reference spectrum.
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3.3. In vitro drug release tests
The drug release profiles at below and above the LCST of the
thermoresponsive copolymer are shown in Fig. 5.An initial con-
trolled release of ibuprofen at both temperatures by poly(NIPAM-
co-MPS)-grafted MSNs was observed. The quantitative release
at 40 °C is lower than at 4 °C. The reverse thermoresponsive
drug release profile was observed due to partial blockage or
plugging of the micropores at the periphery of the particles by
the collapsed globules of the copolymer (refer to Fig. 1). Al-
though a complete blockage of the pores was not observed, a
significant difference in the total final quantitative release of
ibuprofen was obtained. The more controlled and also less
quantitative release above LCST of the copolymer clearly in-
dicated the role of globules in hindering the release of drug.
There are several studies which report the possible size, in the
form of radius of gyration (Rg), of the PNIPAM globules formed
above its LCST in water or water–solvent mixtures [15–18].
A direct relation between the molecular weight of
thermoresponsive polymers and size of globules formed is never
reported. Also none of the studies speculate or directly report
the approximate size or radius of gyration of the globules.
However, some studies report a Rg of globules for free or end-
grafted PNIPAM between 12 and 25 Å, which is very close to
the diameter of the micropores present on MSNs used in this
study [19,20]. Hence the hypothesis of partial blocking of the
micropores by the globules of the copolymer can be sup-
ported.The copolymer in its collapsed state on the micropores
hinders the complete release of ibuprofen above its LCST.
Instead the situation may be reversed in the case of MSNs with
bigger pore diameters where a higher release of drug is ob-
served above LCST of the polymer as the pore volume can be
sufficiently higher to accommodate the globules [6–8].The drug
release profiles obtained thus point out that MSNs with very
small pore diameters may not be a good choice for the prepa-
ration of thermoresponsive DDS.While on the other hand such
Fig. 4 – (A) TGA curves of bare MSNs (solid line), poly(NIPAM-co-MPS)-grafted MSNs (dashed line) and ibuprofen loaded
poly(NIPAM-co-MPS)-grafted MSNs (dotted line). (B) DSC curves of ibuprofen loaded poly(NIPAM-co-MPS)-grafted MSNs
(solid line) and ibuprofen (dotted line).
Fig. 5 – (A) Drug release profiles by poly(NIPAM-co-MPS)-grafted MSNs at 4 °C (solid line) and 40 °C (dotted line). (B)
Magnification of the release profiles up to 7 h.
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reverse thermoresponsive delivery systems can be of great im-
portance where a more controlled or less quantitative release
of active molecules is desired at higher temperatures.
4. Conclusion
In this work thermoresponsive copolymer-grafted bimodal
porous silica nanoparticles were synthesized and their in vitro
drug release profiles were studied. It was observed that, due
the presence of a microporous channel zone, the collapsed de-
hydrated state (globules) of the copolymer obstructs the release
of ibuprofenmolecules above the LCST of the copolymer. Hence
reverse thermoresponsive drug release profiles were ob-
tained. This highlights the importance of the pore diameters
on MSNs for the preparation of thermoresponsive drug deliv-
ery systems. Instead such reverse thermoresponsive release
behavior can be used in therapies where a sustained release
of drug is desired at higher temperatures.
Acknowledgments
Dr. S. A. Jadhav thanks MIUR, Italy for the financial support.
The authors thank Dr. Elena Ugazio for providing porous silica
nanoparticles.
R E F E R E N C E S
[1] Argyo C, Weiss V, Brauchle C, et al. Multifunctional
mesoporous silica nanoparticles as a universal platform for
drug delivery. Chem Mater 2014;26:435–451.
[2] Hu L, Sun C, Song A, et al. Alginate encapsulated
mesoporous silica nanospheres as a sustained drug delivery
system for the poorly water-soluble drug indomethacin.
Asian J Pharm Sci 2014;9:183–190.
[3] Liu L, Li J, Zhao M, et al. Loading of tacrolimus containing
lipid based drug delivery systems into mesoporous silica for
extended release. Asian J Pharm Sci 2016;11:751–759.
[4] Jadhav SA, Brunella V, Berlier G, et al. Effect of multimodal
pore channels on cargo release from mesoporous silica
nanoparticles. J Nanomater 2016;1325174.
[5] Jadhav SA. Incredible pace of research on mesoporous silica
nanoparticles. Inorg Chem Front 2014;1:735–739.
[6] Brunella V, Jadhav SA, Miletto I, et al. Hybrid drug carriers
with temperature-controlled on-off release: a simple and
reliable synthesis of PNIPAM-functionalized mesoporous
silica nanoparticles. React Funct Polym 2016;98:31–37.
[7] Ugazio E, Gastaldi L, Brunella V, et al. Thermoresponsive
mesoporous silica nanoparticles as a carrier for skin
delivery of quercetin. Int J Pharm 2016;511:446–454.
[8] Jadhav SA, Scalarone D, Brunella V, et al. Thermoresponsive
copolymer-grafted SBA-15 porous silica particles for
temperature-triggered topical delivery systems. Express
Polym Lett 2017;11:96–105.
[9] Schild HG. Poly(N-isopropylacrylamide): experiment, theory
and application. Prog Polym Sci 1992;17:163–249.
[10] Taylor P, Heskins M, Guillet JE. Chemistry solution properties
of poly(N-isopropylacrylamide). J Macromol Sci A 2006;8:37–
41.
[11] Jain K, Vedarajan R, Watanabe M, et al. Tunable LCST
behavior of poly(N-isopropylacrylamide/ionic liquid)
copolymers. Polym Chem 2015;6:6819–6825.
[12] Jadhav SA, Brunella V, Scalarone D. Polymerizable ligands as
stabilizers for nanoparticles. Part Part Syst Charact
2015;32:417–428.
[13] Jadhav SA, Miletto I, Brunella V, et al. Controlled post-
synthesis grafting of thermoresponsive poly(N-
isopropylacrylamide) on mesoporous silica nanoparticles.
Polym Adv Technol 2015;26:1070–1075.
[14] Jadhav SA, Brunella V, Miletto I, et al. Synthesis of poly(N-
isopropylacrylamide) by distillation precipitation
polymerization and quantitative grafting on mesoporous
silica. J Appl Polym Sci 2016;133:44181.
[15] Wang X, Qiu X, Wu C. Comparison of the coil-to-globule and
the globule-to-coil transitions of a single poly(N-
isopropylacrylamide) homopolymer chain in water.
Macromolecules 1998;31:2972–2976.
[16] Zeng F, Tong Z, Sato T. Molecular chain properties of poly(N-
isopropyl acrylamide). Sci China B 1999;42:290–297.
[17] Rodríguez-Ropero F, Hajari T, Van Der Vegt NFA. Mechanism
of polymer collapse in miscible good solvents. J Phys Chem B
2015;119:15780–15788.
[18] Bischofberger I, Calzolari DCE, Trappe V. Co-nonsolvency of
PNIPAM at the transition between solvation mechanisms.
Soft Matter 2014;10:8288–8295.
[19] Alaghemandi M, Spohr E. A molecular dynamics study of
poly(N-isopropylacrylamide) endgrafted on a model
cylindrical pore surface. RSC Adv 2013;3:3638–3647.
[20] Deshmukh SA, Li Z, Kamath G, et al. Atomistic insights into
solvation dynamics and conformational transformation in
thermo-sensitive and non-thermo-sensitive oligomers.
Polymer (Guildf) 2013;54:210–222.
284 a s i an j o u rna l o f p h a rma c eu t i c a l s c i e n c e s 1 2 ( 2 0 1 7 ) 2 7 9 – 2 8 4
